Bioptic (6850.TWO) Stock Price

Bioptic Price

CLOSED
31.00
​
Market closed

Over the last 6 years Bioptic grew revenue by 21.8% annually, reaching 202.69 M TWD. Earnings per share have grown at 61.2% per year over the last 5 years. For Bioptic, the net margin of 11.2% is down versus 21.0% a few years ago. At today's price the dividend yield works out to roughly 0.59%. The payout ratio is around 25% of earnings.

Bioptic stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioptic business model & stock analysis

Bioptic Inc, listed on the Taiwan Stock Exchange under ticker 6850.TWO with ISIN TW0006850001, is headquartered in Taipei, Taiwan. The company went public via an IPO on November 10, 2021. Bioptic Inc focuses on the research, development, production, and sale of capillary electrophoresis apparatus and related consumables and nucleic acid detection reagents. Its product portfolio includes testing instruments, cassettes, and reagents. The company's detection equipment features the Qsep100 series, Qsep1 series, and Qsep400 series of capillary electrophoresis instruments designed for the separation and detection of biomolecules. Its cartridge offerings include the S1, S2, S3, and F3 series for DNA fragment detection, R1 and NR1 series for RNA detection, P2 series for protein detection, and quantitative detection Q series. The reagents provided by the company encompass polymerase chain reaction reagents, veterinary medicine-related reagents, human gene detection-related reagents, and food-related reagents. Bioptic Inc primarily serves markets in China, Hong Kong, Taiwan, and other regions. The company's operations are centered around the development and commercialization of specialized equipment and reagents for biomolecular analysis, targeting applications in research, diagnostics, and related fields. The firm's website is https://www.bioptic.com.tw/.

Frequently asked questions about Bioptic

Converted at the current exchange rate, the Bioptic share trades at 0.85 EUR (31.00 TWD).

The revenue cannot currently be calculated for Bioptic.

The profit cannot currently be calculated for Bioptic.

The P/E ratio cannot be calculated for Bioptic at the moment.

The P/S cannot be calculated for Bioptic currently.

The Eulerpool Quality Score for Bioptic is 1/10.

The ISIN of Bioptic is TW0006850001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Bioptic is 6850.TWO. The ticker symbol is used to trade Bioptic shares on the stock exchange.

Fair ValueTerminal
29.76 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Nov 10, 2021
ISIN
TW0006850001
Cusip
Y0907K102
Market capitalization
1.03 B TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
47.77
P/B Ratio
2.28
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
4.24 %
Dividend
Dividend yield
0.59 %
Payout Ratio
25.30 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
4 years
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
21.00 %
Last updated Oct 19, 2026, 12:48 AM

Bioptic Peer Group

Bioptic FIGI

6850:TT (Taipei Stock Exchange) · BBG013F1X4L5

All fundamentals and in-depth analysis of Bioptic

Our stock analysis for Bioptic stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioptic. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.